Welcome to Knowledge Base!

KB at your finger tips

This is one stop global knowledge base where you can learn about all the products, solutions and support features.

Categories
All

Products-Flatiron Health

Revolutionizing Oncology Clinical Decision Support with Flatiron Assist™

Empowering Clinicians with Innovative Treatment Insights

Flatiron Assist™ is an EHR-integrated, oncology-specific clinical decision support platform that revolutionizes the way clinicians access and implement evidence-based medicine, clinical research, and site-specific preferences at the point of care. This powerful tool prioritizes the latest treatment guidelines and insights, ensuring that healthcare providers are equipped with the most up-to-date information to optimize patient care.

Key Features and Benefits

Flatiron Assist™ offers a myriad of features to support clinicians and streamline operations in cancer centers and community oncology practices. By surfacing the latest oncology clinical pathways at the point of care, clinicians can access updated NCCN® Guidelines for various diseases, covering a wide range of orders. The platform also allows for customizable content creation, enabling users to tailor treatment pathways to meet specific preferences. Additionally, Flatiron Assist™ simplifies prior authorization processes, enhances data and reporting capabilities, and identifies clinical trial opportunities based on patient clinical factors.

Positive Outcomes and Testimonials

Flatiron Assist™ has demonstrated significant positive outcomes, including over 90% overall NCCN® concordance, 80% clinician adoption after one year, and a 10% reduction in denial rates. Clinicians have reported a 2-day improvement in time to prior authorization and a 58% reduction in unique regimens ordered, highlighting the platform's impact on improving clinical decision-making and patient outcomes. Testimonials from healthcare professionals like Dr. Sylvia Richey showcase the platform's ease of use and efficiency in accessing critical information.

Partner Spotlight and Success Stories

Leading healthcare providers, such as Penn Medicine's Abramson Cancer Center, have leveraged Flatiron Assist™ to enhance efficiency, improve provider engagement, and increase adoption rates. Dr. Christopher D'Avella's discussion highlighted how the utilization of this platform led to notable improvements in workflow efficiency and patient care delivery. The success stories from partner organizations underscore the transformative potential of Flatiron Assist™ in revolutionizing oncology clinical decision support.

Driving Innovation in Cancer Care

In an evolving landscape of oncology care, Flatiron Assist™ stands out as a pioneering solution that reimagines the infrastructure of cancer care delivery. By providing clinicians with intuitive decision-support tools, actionable data insights, and streamlined workflows, the platform empowers healthcare providers to deliver personalized, evidence-based care to cancer patients. Flatiron Assist™ not only supports clinical decisions in oncology but also contributes to advancing the standard of care in cancer treatment.

Empowering Oncology Research with Real-World Data Solutions from Horizon Datascapes

Tailored Real-World Data Solutions for Oncology Portfolio

Horizon Datascapes, provided by Flatiron Health, offer tailored real-world data solutions to meet the unique needs of oncology portfolios. With over 4 million patient records and 1.5 billion data points, these datasets are designed to address specific use cases efficiently and effectively.

Read article

Revolutionizing Cancer Care: The Impact of Flatiron Health in Oncology Research and Treatment

Who We Are

Flatiron Health is a pioneering healthtech company with a mission to improve and extend lives by learning from the experience of every person with cancer. They believe that this learning process is crucial for accelerating research and enhancing the quality of care in oncology. Their vision is to bridge the gap between care and research using technology and science.

Read article

Revolutionizing Oncology Clinical Trial Recruitment with OncoTrials®

Efficiently match and screen eligible patients

Oncology clinical trial programs are often intricate and multifaceted, presenting a challenge in finding suitable patients for participation. However, with OncoTrials®, this process is simplified and streamlined. Clinical research teams can now swiftly and efficiently assess and confirm eligible trial patients, enhancing the overall recruitment process. By utilizing Electronic Health Record (EHR) data, OncoTrials® enables teams to view filtered and prioritized patients that are at crucial treatment decision points. This not only builds confidence in patient eligibility but also ensures that no potential participant is overlooked. Additionally, the system offers research badges that identify potential patients at the point of care, facilitating proactive patient recruitment.

Read article

Empowering Clinical Trial Diversity: Flatiron Health's Comprehensive Solution

Understanding the Challenge

Clinical trials have long struggled with underrepresentation from various demographic groups, hindering the ability to understand treatment efficacy across different populations. This lack of diversity exacerbates health disparities and limits outcomes for marginalized communities. The FDA's recent guidance mandates sponsors to create diverse action plans to ensure representative testing. Failure to comply could lead to delays and increased costs.

Read article

Revolutionizing Oncology Evidence Generation with Flatiron Horizon

Flexible Real-World Evidence Solutions

Flatiron Health's Evidence Solutions offer a flexible approach to generating both prospective and retrospective real-world evidence. Whether you are conducting ambitious research or facing critical decision points, Flatiron provides the necessary data and support in a manner that helps you achieve your goals efficiently. By leveraging their solutions, researchers can progress faster and gain valuable clinical, analytical, and regulatory assistance.

Read article